The device, which is cleared by the FDA for withdrawal mitigation from opioid use disorder, works by abating severe symptoms such as stomach aches, back aches, sweats, and the inability to keep food ...
State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results